Shire PLC Company Profile (NASDAQ:SHPG)

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company's products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSEVUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), FOSRENOL (lanthanum carbonate), KALBITOR, CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, BUMINATE 25% Albumin (Human), BUMINATE 5% Albumin (Human), GLASSIA Alpha1-Proteinase Inhibitor (Human) and ONCASPAR pegaspargase.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SHPG
  • CUSIP:
Key Metrics:
  • Previous Close: $184.40
  • 50 Day Moving Average: $194.44
  • 200 Day Moving Average: $188.32
  • 52-Week Range: $297,854,000.00 - $147.60
  • Trailing P/E Ratio: 38.32
  • Foreward P/E Ratio: 12.08
  • P/E Growth: 1.06
  • Market Cap: $54.92B
  • Outstanding Shares: 297,854,000
  • Beta: 1.16
  • Net Margins: 13.19%
  • Return on Equity: 17.70%
  • Return on Assets: 8.17%
  • Debt-to-Equity Ratio: 0.72%
  • Current Ratio: 1.41%
  • Quick Ratio: 0.56%
Additional Links:
Companies Related to Shire PLC:

Analyst Ratings

Consensus Ratings for Shire PLC (NASDAQ:SHPG) (?)
Ratings Breakdown: 3 Hold Ratings, 21 Buy Ratings
Consensus Rating:Buy (Score: 2.88)
Consensus Price Target: $225.38 (22.22% upside)

Analysts' Ratings History for Shire PLC (NASDAQ:SHPG)
DateFirmActionRatingPrice TargetDetails
10/23/2016BNP ParibasReiterated RatingBuyView Rating Details
10/17/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
10/16/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
10/8/2016Shore CapitalReiterated RatingBuyView Rating Details
10/1/2016Leerink SwannReiterated RatingBuyView Rating Details
10/1/2016Piper Jaffray Cos.Set Price TargetHold$201.00View Rating Details
9/27/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
9/26/2016HSBCDowngradeBuy -> HoldView Rating Details
9/20/2016Jefferies GroupReiterated RatingBuy$262.00View Rating Details
8/3/2016RBC Capital MarketsReiterated RatingOutperformView Rating Details
8/3/2016GuggenheimReiterated RatingNeutralView Rating Details
7/12/2016BTIG ResearchReiterated RatingBuy$230.00View Rating Details
6/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
6/9/2016Sanford C. BernsteinReiterated RatingOutperform$222.00View Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightView Rating Details
5/26/2016Stifel NicolausInitiated CoverageBuy$230.00View Rating Details
5/23/2016Bryan, Garnier & CoInitiated CoverageBuyView Rating Details
5/6/2016Liberum CapitalInitiated CoverageBuyView Rating Details
5/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details
3/30/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
2/26/2016Cantor FitzgeraldInitiated CoverageBuyView Rating Details
2/13/2016Northland SecuritiesReiterated RatingBuyView Rating Details
2/8/2016SusquehannaLower Price TargetPositive$280.00 -> $220.00View Rating Details
1/18/2016Credit Suisse Group AGUpgradeBuyView Rating Details
10/21/2015William BlairReiterated RatingOutperform$276.00View Rating Details
9/21/2015Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details
7/16/2015Berenberg BankInitiated CoverageBuyView Rating Details
6/8/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
5/6/2015Kepler Capital MarketsReiterated RatingBuyView Rating Details
1/12/2015S&P Equity ResearchDowngradeStrong-Buy -> BuyView Rating Details
1/5/2015Panmure GordonReiterated RatingBuyView Rating Details
10/27/2014CRT CapitalReiterated RatingBuy$225.00 -> $233.00View Rating Details
(Data available from 10/23/2014 forward)


Earnings History for Shire PLC (NASDAQ:SHPG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$3.03$3.38$2.28 billion$2.43 millionViewN/AView Earnings Details
4/29/2016Q1$3.05$3.19$1.71 billion$1.71 billionViewListenView Earnings Details
2/11/2016Q415$2.89$2.97$1.69 million$1.72 billionViewListenView Earnings Details
10/23/2015Q315$2.87$3.24$1.63 billion$1.58 billionViewListenView Earnings Details
7/23/2015Q215$2.81$2.63$1.59 billion$1.56 billionViewListenView Earnings Details
4/30/2015Q115$2.56$2.84$1.47 billion$1.49 billionViewN/AView Earnings Details
2/12/2015Q115$2.68$2.63$1.58 billionViewN/AView Earnings Details
10/24/2014Q314$2.47$2.93$1.46 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$2.45$2.67$1.45 billion$1.50 billionViewN/AView Earnings Details
5/1/2014Q114$2.22$2.36$1.38 billion$1.35 billionViewN/AView Earnings Details
2/13/2014Q413$2.02$2.26$1.28 billion$1.33 billionViewN/AView Earnings Details
10/24/2013Q213$1.65$1.77$1.23 billion$1.24 billionViewN/AView Earnings Details
7/25/2013$1.60$1.79$1.21 billion$1.28 billionViewN/AView Earnings Details
5/2/2013Q113$1.56$1.63$1.21 billion$1.16 billionViewN/AView Earnings Details
2/14/2013Q412$1.58$1.58$1.20 billion$1.20 billionViewN/AView Earnings Details
10/25/2012$1.47$1.36ViewN/AView Earnings Details
8/1/2012$1.52$1.68ViewN/AView Earnings Details
4/26/2012$0.52$1.24ViewN/AView Earnings Details
2/9/2012$0.48$0.44ViewN/AView Earnings Details
10/28/2011$1.31$1.28ViewN/AView Earnings Details
7/28/2011$1.24$1.33ViewN/AView Earnings Details
4/28/2011$1.18$1.23ViewN/AView Earnings Details
2/10/2011$1.04$1.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Shire PLC (NASDAQ:SHPG)
Current Year EPS Consensus Estimate: $12.92 EPS
Next Year EPS Consensus Estimate: $15.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$2.76$3.17$3.01
Q2 20164$3.05$3.23$3.13
Q3 20164$3.00$3.30$3.19
Q4 20164$3.20$3.41$3.28
(Data provided by Zacks Investment Research)


Current Dividend Information for Shire PLC (NASDAQ:SHPG)
Annual Dividend:$0.80
Dividend Yield:0.43%
Payout Ratio:15.63% (Based on Trailing 12 Months of Earnings)
6.19% (Based on Current Year Consensus EPS Estimate)
5.24% (Based on Next Year Consensus EPS Estimate)

Dividend History for Shire PLC (NASDAQ:SHPG)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (NASDAQ:SHPG)
No insider trades for this company have been tracked by


Latest Headlines for Shire PLC (NASDAQ:SHPG)
DateHeadline logoShire Plc : SHPG-US: Dividend Analysis : September 09th, 2016 (record date) : By the numbers : October 20, 2016 (NASDAQ:SHPG) - October 20 at 7:36 PM
News IconStock in Focus- Shire plc's (SHPG) - Hot Stocks Point (NASDAQ:SHPG) - October 20 at 6:18 AM
News IconShire PLC's (SHPG) Buy Rating Reiterated at Goldman Sachs Group Inc (NASDAQ:SHPG) - October 19 at 7:57 PM logoSHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:SHPG) - October 19 at 7:57 PM logoShire's (SHPG) ONIVYDE Receives EC Marketing Authorization for ... - (NASDAQ:SHPG) - October 18 at 12:38 PM logoMerrimack's Cancer Drug Wins EU Nod (MACK, SHPG) (NASDAQ:SHPG) - October 18 at 12:38 PM
News IconLeading stocks in today’s market: Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - October 17 at 7:08 PM logoEli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing (NASDAQ:SHPG) - October 17 at 7:08 PM logoMultimedia Assets Available: Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease (NASDAQ:SHPG) - October 17 at 12:35 PM logoShire Updates Vyvanse U.S. Labeling To Include New Efficacy Data - Quick Facts (NASDAQ:SHPG) - October 17 at 12:35 PM
News IconFund Move to Note: Sphera Funds Management LTD Position in ... - Chester News (NASDAQ:SHPG) - October 15 at 6:52 PM
News IconPros Don't Lie: Shire Plc (SHPG) Holder Blue Jay Capital Management LLC Cut Its Stake as Share Price Rose - Chester News (NASDAQ:SHPG) - October 15 at 6:52 PM logoBioMarin Issues Encouraging Update on Hemophilia A Drug (NASDAQ:SHPG) - October 14 at 10:34 AM
News IconHigh Market Cap Stock of the Day – Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - October 13 at 7:29 PM
News IconVanguard Group Inc. Invests $278421000 in Shire PLC (SHPG) - DailyQuint (NASDAQ:SHPG) - October 12 at 7:15 PM logoMartin Whitman's Top Recent Investments (NASDAQ:SHPG) - October 12 at 7:15 PM logoShire plc to Join the NASDAQ-100 Index Beginning... (NASDAQ:SHPG) - October 12 at 9:49 AM logoShire plc to Join the NASDAQ-100 Index Beginning October 19, 2016 (NASDAQ:SHPG) - October 11 at 8:11 PM logoShire close to deal for Radius Health (NASDAQ:SHPG) - October 11 at 2:16 PM
News IconLarge Cap Drug Manufacturers – Major: Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - October 11 at 2:16 PM logoAllergan Challenges Intercept With Tobira NASH Drug (NASDAQ:SHPG) - October 11 at 2:16 PM
News IconStocks Under Review: Shire PLC (ADR)(NASDAQ:SHPG),Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) - NYSE Journal (press release) (NASDAQ:SHPG) - October 10 at 6:47 PM logo[$$] Baxalta Could Boost Shire Shares More Than 25% (NASDAQ:SHPG) - October 8 at 11:48 AM
News IconActive Movers in Hot Line: Shire (NASDAQ:SHPG), Alnylam ... - Street Wise Report (press release) (blog) (NASDAQ:SHPG) - October 7 at 12:32 PM
News IconFiling Analysis: Md Sass Investors Services INC Has Increased Its Shire Plc (SHPG) Position by $20.57 Million; Stock ... - Chester News (NASDAQ:SHPG) - October 7 at 12:32 PM logo5 Stock Picks Ahead of World Mental Health Day (NASDAQ:SHPG) - October 7 at 12:32 PM logoShire (SHPG) Affirms Positive PTAB Decision to Uphold LIALDA Patent (NASDAQ:SHPG) - October 6 at 7:02 PM logoKyle Bass Is ‘Frustrated’ by Shire’s Lialda Patent Ruling (NASDAQ:SHPG) - October 6 at 7:02 PM logoJohn Paulson's Health Care Picks Drop in Flat Year for Sector (NASDAQ:SHPG) - October 6 at 7:02 PM logoShire (SHPG) Affirms Positive PTAB Decision to Uphold LIALDA Patent - (NASDAQ:SHPG) - October 6 at 12:53 PM logoKamada (KMDA), Shire (SHPG) Extend GLASSIA Supply and Distribution Agreement - (NASDAQ:SHPG) - October 6 at 12:53 PM
News IconActive Stocks in 'How' and 'Why'- Shire plc (NASDAQ:SHPG), KLA-Tencor (NASDAQ:KLAC), MetLife9 (NYSE:MET) - Seneca Globe (NASDAQ:SHPG) - October 6 at 12:53 PM logoPatent Trial and Appeal Board Upholds the Validity of LIALDA® Patent (NASDAQ:SHPG) - October 5 at 7:10 PM
News IconShire Files 8K - Other Events (NASDAQ:SHPG) - October 4 at 6:50 PM
News IconShire Plc (NASDAQ:SHPG) Updated Broker Price Targets - The De ... - The De Soto Edge (NASDAQ:SHPG) - October 2 at 6:17 PM
News IconSHIRE PLC - Director/PDMR Shareholding (NASDAQ:SHPG) - October 2 at 11:11 AM logoExpected For Shire plc (NASDAQ:SHPG) Sales Of $22023.42 - Investor Newswire (NASDAQ:SHPG) - October 1 at 6:23 PM
News IconLooking at This Dividend Stock With Upside Possibility: Shire plc (NASDAQ:SHPG) - Post News (NASDAQ:SHPG) - September 30 at 7:37 PM
News IconShire plc (NASDAQ:SHPG) missed earnings on 2 occasions - The Independent Republic (NASDAQ:SHPG) - September 30 at 2:30 PM logoMorgan Stanley Starts Coverage on Shire plc (SHPG) Giving It An Initial Rating Of "Overweight" - Finance Daily (NASDAQ:SHPG) - September 30 at 2:30 PM logoShire Cedes Biosimilar Field - Seeking Alpha (NASDAQ:SHPG) - September 30 at 2:30 PM
News IconVodafone Group Plc (NASDAQ: VOD) - Analysis of a Large Market Cap Stock (NASDAQ:SHPG) - September 29 at 12:42 PM logoGALT In A Fix, SHPG Ends Biosimilar Deals, KTOV Moves Closer To File KIT-302 NDA - RTT News (NASDAQ:SHPG) - September 28 at 12:32 PM
News IconWatch List: Shire PLC (ADR) (NASDAQ:SHPG), Take-Two ... - NYSE Journal (press release) (NASDAQ:SHPG) - September 28 at 12:32 PM
News IconTop Gainers of the Day: Shire plc (NASDAQ:SHPG) from Drug Manufacturers – Major (NASDAQ:SHPG) - September 27 at 7:11 PM
News IconShire plc (NASDAQ:SHPG) from Drug Manufacturers – Major – Todays Top Gains (NASDAQ:SHPG) - September 26 at 7:20 PM logoShire plc downgraded by HSBC Securities (NASDAQ:SHPG) - September 26 at 7:20 PM logoShire : Files 8K - Other Events (NASDAQ:SHPG) - September 25 at 1:32 PM logoAmgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest (NASDAQ:SHPG) - September 23 at 6:43 PM
News IconDrug Manufacturers – Major: Shire plc (NASDAQ:SHPG) Position of the day (NASDAQ:SHPG) - September 23 at 11:57 AM


Shire PLC (NASDAQ:SHPG) Chart for Sunday, October, 23, 2016

Last Updated on 10/23/2016 by Staff